Education
About Us
Working with TipRanks
Follow Us
IPCA Laboratories Limited (IN:IPCALAB)
:IPCALAB
Total Valuation
IPCA Laboratories Limited has a market cap or net worth of ₹338.39B. The enterprise value is ₹327.15B.
Market Cap₹338.39B
Enterprise Value₹327.15B
Share Statistics
IPCA Laboratories Limited has 253,704,220 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding253,704,220
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
IPCA Laboratories Limited’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 9.12%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)9.12%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.76
Inventory Turnover2.02
Valuation Ratios
The current PE Ratio of IPCA Laboratories Limited is 0.00. IPCA Laboratories Limited’s PEG ratio is 0.32.
PE Ratio0.00
PS Ratio0.00
PB Ratio3.94
Price to Fair Value0.00
Price to FCF39.42
Price to Operating Cash Flow24.96
PEG Ratio0.32
Income Statement
In the last 12 months, IPCA Laboratories Limited had revenue of 89.40B and earned 7.38B in profits. Earnings per share was 29.08.
Revenue89.40B
Gross Profit37.79B
Operating Income13.28B
Pretax Income11.31B
Net Income7.38B
EBITDA16.14B
Earnings Per Share (EPS)29.08
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
IPCA Laboratories Limited pays an annual dividend of ₹4, resulting in a dividend yield of 0.59%
Dividend Per Share₹4
Dividend Yield0.59%
Payout Ratio5.80%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.62
52-Week Price Change17.90%
50-Day Moving Average1.40K
200-Day Moving Average1.48K
Relative Strength Index (RSI)38.33
Average Volume (3m)6.67K
Important Dates
IPCA Laboratories Limited upcoming earnings date is Aug 19, 2025, TBA (Confirmed).
Last Earnings DateMay 29, 2025
Next Earnings DateAug 19, 2025
Ex-Dividend DateAug 05, 2025
Financial Position
IPCA Laboratories Limited as a current ratio of 2.50, with Debt / Equity ratio of 14.89%
Current Ratio2.50
Quick Ratio1.43
Debt to Market Cap0.00
Net Debt to EBITDA0.63
Interest Coverage Ratio15.64
Taxes
In the past 12 months, IPCA Laboratories Limited has paid 3.44B in taxes.
Income Tax3.44B
Effective Tax Rate0.30
Enterprise Valuation
IPCA Laboratories Limited EV to EBITDA ratio is 0.63, with an EV/FCF ratio of 2.04.
EV to Sales0.11
EV to EBITDA0.63
EV to Free Cash Flow2.04
EV to Operating Cash Flow0.80
Balance Sheet
IPCA Laboratories Limited has ₹9.03B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹9.03B billion.
Cash & Marketable Securities₹9.03B
Total Debt₹0.00
Net Cash-₹9.03B
Net Cash Per Share-₹35.60
Tangible Book Value Per Share₹0.00
Margins
Gross margin is 65.05%, with operating margin of 14.86%, and net profit margin of 8.25%.
Gross Margin65.05%
Operating Margin14.86%
Pretax Margin12.65%
Net Profit Margin8.25%
EBITDA Margin18.05%
EBIT Margin13.60%
Analyst Forecast
The average price target for IPCA Laboratories Limited is ₹1,435.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target₹1,435.00
Price Target Upside-4.06% Downside
Analyst ConsensusHold
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―